Grupo Azevedos
About Grupo Azevedos
Certifications
Categories
-
Country/Region:Portugal
-
On CPHI since:2015
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
Meet us at
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
Products from Grupo Azevedos (51)
-
Product Dimenhydrinate
- Active substance(s): Dimenhydrinate
- Pharmaceutical form(s): Tablets
- Strength(s): 50 mg -
Product Generic (Paracetamol + Thiocolchicoside )
- Active substance(s): Paracetamol + Thiocolchicoside
- Pharmaceutical form(s): Tablets
- Strength(s): 500 mg + 2 mg -
Product Generic (Parecoxib)
- Active substance(s): Parecoxib
- Pharmaceutical form(s): Powder for solution for infusion
- Strength(s): 40 mg – IV
-
Product Generic (Fosaprepitant)
- Active substance(s): Fosaprepitant
- Pharmaceutical form(s): Powder for solution for infusion
- Strength(s): 150 mg – IV
-
Product Generic (Voriconazole)
- Active substance(s): Voriconazole
- Pharmaceutical form(s): Powder for Solution for infusion
- Strength(s):200 mg – IV
-
Product Generic (Irbesartan)
- Active substance(s): Irbesartan;
- Pharmaceutical form(s): Tablets
- Strength(s): 75 mg; 150 mg; 300 mg -
Product Generic (Sinvastatin)
- Active substance(s): Sinvastatin;
- Pharmaceutical form(s): Tablets
- Strength(s): 10 mg; 20 mg; 40 mg -
Product Generic (Rosuvastatin)
- Active substance(s): Rosuvastatin;
- Pharmaceutical form(s): Tablets
- Strength(s): 5 mg; 10 mg; 20 mg; 40 mg -
Product Generic (Lovastatin)
- Active substance(s): Lovastatin;
- Pharmaceutical form(s): Tablets
- Strength(s): 10 mg; 20 mg; 40 mg -
Product Generic (Atorvastatin)
- Active substance(s): Atorvastatin
- Pharmaceutical form(s): Tablets
- Strength(s): 10 mg; 20 mg; 40 mg; 80 mg -
Product Generic (Perindopril + Indapamide)
- Active substance(s): Perindopril + Indapamide;
- Pharmaceutical form(s): Tablets
- Strength(s): 2 + 0,625 mg; 4 + 1,25 mg -
Product Generic (Perindopril)
- Active substance(s): Perindopril;
- Pharmaceutical form(s): Tablets
- Strength(s): 2 mg, 4 mg, 8 mg
















































